Vertex Pharma (VRTX) Tops Q1 EPS by 13c
Tweet
Share
E-mailGet Alerts VRTX Hot Sheet
Price: $552.06 +4.52%
Financial Fact:
Net loss attributable to noncontrolling interest (Alios): 696K
Today's EPS Names:
JAGX, CLIR, ZTO, More
Financial Fact:
Net loss attributable to noncontrolling interest (Alios): 696K
Today's EPS Names:
JAGX, CLIR, ZTO, More
Join SI Premium – FREE
Vertex Pharma (NASDAQ: VRTX) reported Q1 EPS of ($0.62), $0.13 better than the analyst estimate of ($0.75). Revenue for the quarter came in at $138.5 million versus the consensus estimate of $142.38 million.
For earnings history and earnings-related data on Vertex Pharma (VRTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Analog Devices climbs as fiscal Q3 results, Q4 outlook beat forecasts
- Bill.com (BILL) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
